2.4.0.6 Html 371 272 1 false 53 0 false 5 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.cytosorbents.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.cytosorbents.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cytosorbents.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.cytosorbents.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 005 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.cytosorbents.com/role/ConsolidatedStatementOfChangesInStockholdersEquityDeficit CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) false false R6.htm 006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Sheet http://www.cytosorbents.com/role/ConsolidatedStatementOfChangesInStockholdersEquityDeficitParenthetical CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) false false R7.htm 007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cytosorbents.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://www.cytosorbents.com/role/ConsolidatedStatementsOfCashFlowsParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) false false R9.htm 101 - Disclosure - BASIS OF PRESENTATION Sheet http://www.cytosorbents.com/role/BasisOfPresentation BASIS OF PRESENTATION false false R10.htm 102 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.cytosorbents.com/role/PrincipalBusinessActivityAndSummaryOfSignificantAccountingPolicies PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R11.htm 103 - Disclosure - CONVERTIBLE NOTES Notes http://www.cytosorbents.com/role/ConvertibleNotes CONVERTIBLE NOTES false false R12.htm 1031 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://www.cytosorbents.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET false false R13.htm 104 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficit STOCKHOLDERS' EQUITY (DEFICIT) false false R14.htm 1041 - Disclosure - OTHER ASSETS Sheet http://www.cytosorbents.com/role/OtherAssets OTHER ASSETS false false R15.htm 105 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.cytosorbents.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R16.htm 1051 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES Sheet http://www.cytosorbents.com/role/AccountsPayableAndAccruedExpenses ACCOUNTS PAYABLE AND ACCRUED EXPENSES false false R17.htm 106 - Disclosure - NET LOSS PER SHARE Sheet http://www.cytosorbents.com/role/NetLossPerShare NET LOSS PER SHARE false false R18.htm 107 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.cytosorbents.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R19.htm 1071 - Disclosure - INCOME TAXES Sheet http://www.cytosorbents.com/role/IncomeTaxes INCOME TAXES false false R20.htm 202 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) Sheet http://www.cytosorbents.com/role/PrincipalBusinessActivityAndSummaryOfSignificantAccountingPoliciesPolicy PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy) false false R21.htm 304 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Tables) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitTables STOCKHOLDERS' EQUITY (DEFICIT) (Tables) false false R22.htm 40101 - Disclosure - BASIS OF PRESENTATION (Details) Sheet http://www.cytosorbents.com/role/BasisOfPresentationDetails BASIS OF PRESENTATION (Details) false false R23.htm 40201 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.cytosorbents.com/role/PrincipalBusinessActivityAndSummaryOfSignificantAccountingPoliciesDetails PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) false false R24.htm 40301 - Disclosure - CONVERTIBLE NOTES (Details) Notes http://www.cytosorbents.com/role/ConvertibleNotesDetails CONVERTIBLE NOTES (Details) false false R25.htm 40401 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Narrative) (Details) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitNarrativeDetails STOCKHOLDERS' EQUITY (DEFICIT) (Narrative) (Details) false false R26.htm 40402 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Summary of Stock Option Activity) (Details) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitSummaryOfStockOptionActivityDetails STOCKHOLDERS' EQUITY (DEFICIT) (Summary of Stock Option Activity) (Details) false false R27.htm 40403 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Summary of Status of Non-Vested Options) (Details) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitSummaryOfStatusOfNonVestedOptionsDetails STOCKHOLDERS' EQUITY (DEFICIT) (Summary of Status of Non-Vested Options) (Details) false false R28.htm 40404 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Schedule of Warrants to Purchase Common Stock) (Details) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitScheduleOfWarrantsToPurchaseCommonStockDetails STOCKHOLDERS' EQUITY (DEFICIT) (Schedule of Warrants to Purchase Common Stock) (Details) false false R29.htm 40501 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.cytosorbents.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) false false R30.htm 40601 - Disclosure - NET LOSS PER SHARE (Details) Sheet http://www.cytosorbents.com/role/NetLossPerShareDetails NET LOSS PER SHARE (Details) false false R31.htm 40701 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.cytosorbents.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) false false All Reports Book All Reports Element ctso_StockIssuedDuringPeriodSharesNewIssuesPreferredStock had a mix of decimals attribute values: 0 2. Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights had a mix of decimals attribute values: 2 3 4. Element us-gaap_ConversionOfStockSharesConverted1 had a mix of decimals attribute values: 0 2. Element us-gaap_EquityIssuancePerShareAmount had a mix of decimals attribute values: 1 2 3. Element us-gaap_PreferredStockDividendsShares had a mix of decimals attribute values: 0 2. Element us-gaap_PreferredStockSharesIssued had a mix of decimals attribute values: 0 2. Element us-gaap_PreferredStockSharesOutstanding had a mix of decimals attribute values: 0 2. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice had a mix of decimals attribute values: 1 3. Element us-gaap_SharesOutstanding had a mix of decimals attribute values: 0 2. Element us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities had a mix of decimals attribute values: 0 2. Process Flow-Through: 002 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: Removing column 'Dec. 31, 2008' Process Flow-Through: Removing column 'Dec. 31, 2007' Process Flow-Through: Removing column 'Dec. 31, 2006' Process Flow-Through: Removing column 'Dec. 31, 2005' Process Flow-Through: Removing column 'Dec. 31, 2004' Process Flow-Through: Removing column 'Dec. 31, 2003' Process Flow-Through: Removing column 'Dec. 31, 2002' Process Flow-Through: Removing column 'Dec. 31, 2001' Process Flow-Through: Removing column 'Dec. 31, 2000' Process Flow-Through: Removing column 'Dec. 31, 1999' Process Flow-Through: Removing column 'Dec. 31, 1998' Process Flow-Through: Removing column 'Dec. 31, 1997' Process Flow-Through: Removing column 'Jan. 21, 1997' Process Flow-Through: 003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '11 Months Ended Dec. 31, 1997' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2009' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2007' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2006' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2005' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2004' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2003' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2002' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2001' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2000' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 1999' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 1998' Process Flow-Through: 006 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Process Flow-Through: 007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: 008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) ctso-20121212.xml ctso-20121212.xsd ctso-20121212_cal.xml ctso-20121212_def.xml ctso-20121212_lab.xml ctso-20121212_pre.xml true true